Cell-nano  interactions of polydopamine nanoparticles
Curr Opin Biotechnol. 2023 Oct 26;84:103013. doi: 10.1016/j.copbio.2023.103013. Online ahead of print.ABSTRACTPolydopamine (PDA) nanoparticles (NPs) have diverse nanomedicine applications owing to their biocompatibility and abundant entry to cells. Yet, our knowledge in their interactions with cells was infrequently studied until recent years. This review presents the latest insights into the cell-nano interactions of PDA NPs, including their 'self-targeting' to dopamine receptors for cellular entry without the aid of ligands, in vitro 'self-therapeutic' cellular responses (antiferroptosis, macrophage polarization, and mod...
Source: Current Opinion in Biotechnology - October 28, 2023 Category: Biotechnology Authors: Zhihui Liang Yuan He Christina Su Ieong Chung Hang Jonathan Choi Source Type: research

Cell-nano  interactions of polydopamine nanoparticles
Curr Opin Biotechnol. 2023 Oct 26;84:103013. doi: 10.1016/j.copbio.2023.103013. Online ahead of print.ABSTRACTPolydopamine (PDA) nanoparticles (NPs) have diverse nanomedicine applications owing to their biocompatibility and abundant entry to cells. Yet, our knowledge in their interactions with cells was infrequently studied until recent years. This review presents the latest insights into the cell-nano interactions of PDA NPs, including their 'self-targeting' to dopamine receptors for cellular entry without the aid of ligands, in vitro 'self-therapeutic' cellular responses (antiferroptosis, macrophage polarization, and mod...
Source: Current Opinion in Biotechnology - October 28, 2023 Category: Biotechnology Authors: Zhihui Liang Yuan He Christina Su Ieong Chung Hang Jonathan Choi Source Type: research

Cell-nano  interactions of polydopamine nanoparticles
Curr Opin Biotechnol. 2023 Oct 26;84:103013. doi: 10.1016/j.copbio.2023.103013. Online ahead of print.ABSTRACTPolydopamine (PDA) nanoparticles (NPs) have diverse nanomedicine applications owing to their biocompatibility and abundant entry to cells. Yet, our knowledge in their interactions with cells was infrequently studied until recent years. This review presents the latest insights into the cell-nano interactions of PDA NPs, including their 'self-targeting' to dopamine receptors for cellular entry without the aid of ligands, in vitro 'self-therapeutic' cellular responses (antiferroptosis, macrophage polarization, and mod...
Source: Current Opinion in Biotechnology - October 28, 2023 Category: Biotechnology Authors: Zhihui Liang Yuan He Christina Su Ieong Chung Hang Jonathan Choi Source Type: research

Modulation of immune cells with mRNA nanoformulations for cancer immunotherapy
Curr Opin Biotechnol. 2023 Oct 20;84:103014. doi: 10.1016/j.copbio.2023.103014. Online ahead of print.ABSTRACTThe global adaptation of mRNA vaccines to protect against the COVID-19 pandemic was a major interdisciplinary milestone, demonstrating the potential of combining mRNA applications with nanotechnology. This innovative strategy holds great promise as an improved therapeutic modality for cancer immunotherapy, as further development could facilitate targeted mRNA delivery to specific immune cells and enable manipulation of effector functions. Toward this, researchers have made substantial efforts to modulate various im...
Source: Current Opinion in Biotechnology - October 22, 2023 Category: Biotechnology Authors: Junhee Han Ji-Ho Park Source Type: research

Modulation of immune cells with mRNA nanoformulations for cancer immunotherapy
Curr Opin Biotechnol. 2023 Oct 20;84:103014. doi: 10.1016/j.copbio.2023.103014. Online ahead of print.ABSTRACTThe global adaptation of mRNA vaccines to protect against the COVID-19 pandemic was a major interdisciplinary milestone, demonstrating the potential of combining mRNA applications with nanotechnology. This innovative strategy holds great promise as an improved therapeutic modality for cancer immunotherapy, as further development could facilitate targeted mRNA delivery to specific immune cells and enable manipulation of effector functions. Toward this, researchers have made substantial efforts to modulate various im...
Source: Current Opinion in Biotechnology - October 22, 2023 Category: Biotechnology Authors: Junhee Han Ji-Ho Park Source Type: research

Modulation of immune cells with mRNA nanoformulations for cancer immunotherapy
Curr Opin Biotechnol. 2023 Oct 20;84:103014. doi: 10.1016/j.copbio.2023.103014. Online ahead of print.ABSTRACTThe global adaptation of mRNA vaccines to protect against the COVID-19 pandemic was a major interdisciplinary milestone, demonstrating the potential of combining mRNA applications with nanotechnology. This innovative strategy holds great promise as an improved therapeutic modality for cancer immunotherapy, as further development could facilitate targeted mRNA delivery to specific immune cells and enable manipulation of effector functions. Toward this, researchers have made substantial efforts to modulate various im...
Source: Current Opinion in Biotechnology - October 22, 2023 Category: Biotechnology Authors: Junhee Han Ji-Ho Park Source Type: research

Modulation of immune cells with mRNA nanoformulations for cancer immunotherapy
Curr Opin Biotechnol. 2023 Oct 20;84:103014. doi: 10.1016/j.copbio.2023.103014. Online ahead of print.ABSTRACTThe global adaptation of mRNA vaccines to protect against the COVID-19 pandemic was a major interdisciplinary milestone, demonstrating the potential of combining mRNA applications with nanotechnology. This innovative strategy holds great promise as an improved therapeutic modality for cancer immunotherapy, as further development could facilitate targeted mRNA delivery to specific immune cells and enable manipulation of effector functions. Toward this, researchers have made substantial efforts to modulate various im...
Source: Current Opinion in Biotechnology - October 22, 2023 Category: Biotechnology Authors: Junhee Han Ji-Ho Park Source Type: research

Modulation of immune cells with mRNA nanoformulations for cancer immunotherapy
Curr Opin Biotechnol. 2023 Oct 20;84:103014. doi: 10.1016/j.copbio.2023.103014. Online ahead of print.ABSTRACTThe global adaptation of mRNA vaccines to protect against the COVID-19 pandemic was a major interdisciplinary milestone, demonstrating the potential of combining mRNA applications with nanotechnology. This innovative strategy holds great promise as an improved therapeutic modality for cancer immunotherapy, as further development could facilitate targeted mRNA delivery to specific immune cells and enable manipulation of effector functions. Toward this, researchers have made substantial efforts to modulate various im...
Source: Current Opinion in Biotechnology - October 22, 2023 Category: Biotechnology Authors: Junhee Han Ji-Ho Park Source Type: research

Proline metabolism shapes the tumor microenvironment: from collagen deposition to immune evasion
Curr Opin Biotechnol. 2023 Oct 19;84:103011. doi: 10.1016/j.copbio.2023.103011. Online ahead of print.ABSTRACTProline is a nonessential amino acid, and its metabolism has been implicated in numerous malignancies. Together with a direct role in regulating cancer cells' proliferation and survival, proline metabolism plays active roles in shaping the tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) display high rates of proline biosynthesis to support the production of collagen for the extracellular matrix (ECM). Indeed, impaired proline metabolism in CAFs results in reduced collagen deposition and compromis...
Source: Current Opinion in Biotechnology - October 21, 2023 Category: Biotechnology Authors: Emily J Kay Sara Zanivan Alessandro Rufini Source Type: research

Proline metabolism shapes the tumor microenvironment: from collagen deposition to immune evasion
Curr Opin Biotechnol. 2023 Oct 19;84:103011. doi: 10.1016/j.copbio.2023.103011. Online ahead of print.ABSTRACTProline is a nonessential amino acid, and its metabolism has been implicated in numerous malignancies. Together with a direct role in regulating cancer cells' proliferation and survival, proline metabolism plays active roles in shaping the tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) display high rates of proline biosynthesis to support the production of collagen for the extracellular matrix (ECM). Indeed, impaired proline metabolism in CAFs results in reduced collagen deposition and compromis...
Source: Current Opinion in Biotechnology - October 21, 2023 Category: Biotechnology Authors: Emily J Kay Sara Zanivan Alessandro Rufini Source Type: research

O-GlcNAcylation at the center of antitumor immunity
Curr Opin Biotechnol. 2023 Oct 18;84:103009. doi: 10.1016/j.copbio.2023.103009. Online ahead of print.ABSTRACTThe post-translational modification known as O-GlcNAcylation is a highly dysregulated process in tumors, and a key contributor to malignant transformation. In contrast, after three decades since its discovery, very little has been revealed about this process in the immune system. With the prospect of targeting O-GlcNAcylation as tumor therapy, greater understanding of how it regulates immune responses in the context of the tumor microenvironment will be needed. Here, we discuss recent discoveries from which a pictu...
Source: Current Opinion in Biotechnology - October 20, 2023 Category: Biotechnology Authors: Graham A Heieis Bart Everts Source Type: research

Nucleotide metabolism in the regulation of tumor microenvironment and immune cell function
Curr Opin Biotechnol. 2023 Oct 18;84:103008. doi: 10.1016/j.copbio.2023.103008. Online ahead of print.ABSTRACTNucleotide metabolism plays a crucial role in the regulation of the tumor microenvironment (TME) and immune cell function. In the TME, limited availability of nucleotide precursors due to increased consumption by tumor cells and T cells affects both tumor development and immune function. Metabolic reprogramming in tumor cells favors pathways supporting growth and proliferation, including nucleotide synthesis. Additionally, extracellular nucleotides, such as ATP and adenosine, exhibit dual roles in modulating immune...
Source: Current Opinion in Biotechnology - October 20, 2023 Category: Biotechnology Authors: Helena B Madsen Marlies Jw Peeters Per Thor Straten Claus Desler Source Type: research

Interactions between nanoparticle corona proteins and the immune system
Curr Opin Biotechnol. 2023 Oct 16;84:103010. doi: 10.1016/j.copbio.2023.103010. Online ahead of print.ABSTRACTThe corona surrounding nanoparticles (NPs) in serum contains proteins such as complement, immunoglobulins, and apolipoproteins that can interact with the immune system. This review article describes the impact of these interactions on nanomedicine stability, biodistribution, efficacy, and safety. Notably, it highlights the latest findings on the generation of antibody responses to the polyethylene glycol (PEG) component of SARS-CoV-2 mRNA vaccines and possible mechanisms of hypersensitivity reactions induced by ant...
Source: Current Opinion in Biotechnology - October 18, 2023 Category: Biotechnology Authors: Trieu Tm Tran Steve R Roffler Source Type: research

Interactions between nanoparticle corona proteins and the immune system
Curr Opin Biotechnol. 2023 Oct 16;84:103010. doi: 10.1016/j.copbio.2023.103010. Online ahead of print.ABSTRACTThe corona surrounding nanoparticles (NPs) in serum contains proteins such as complement, immunoglobulins, and apolipoproteins that can interact with the immune system. This review article describes the impact of these interactions on nanomedicine stability, biodistribution, efficacy, and safety. Notably, it highlights the latest findings on the generation of antibody responses to the polyethylene glycol (PEG) component of SARS-CoV-2 mRNA vaccines and possible mechanisms of hypersensitivity reactions induced by ant...
Source: Current Opinion in Biotechnology - October 18, 2023 Category: Biotechnology Authors: Trieu Tm Tran Steve R Roffler Source Type: research

Interactions between nanoparticle corona proteins and the immune system
Curr Opin Biotechnol. 2023 Oct 16;84:103010. doi: 10.1016/j.copbio.2023.103010. Online ahead of print.ABSTRACTThe corona surrounding nanoparticles (NPs) in serum contains proteins such as complement, immunoglobulins, and apolipoproteins that can interact with the immune system. This review article describes the impact of these interactions on nanomedicine stability, biodistribution, efficacy, and safety. Notably, it highlights the latest findings on the generation of antibody responses to the polyethylene glycol (PEG) component of SARS-CoV-2 mRNA vaccines and possible mechanisms of hypersensitivity reactions induced by ant...
Source: Current Opinion in Biotechnology - October 18, 2023 Category: Biotechnology Authors: Trieu Tm Tran Steve R Roffler Source Type: research